BD BBL™ Martin-Lewis Agar 221557Recalls & reported problems

Becton, Dickinson And Company · Plate Martin-Lewis Agar 20 Ea · Class 2

All models of BD BBL Martin-Lewis Agar (2)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports: 0
Deaths reported: 0
Injuries reported: 0
Recalls naming it: 1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier.

1 other recall cover devices cleared under the same FDA submission (K770287); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

Mar 17, 2021Class IITerminated
Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation) and reduce the identification of Neisseria contributing to a delay in time to definitive diagnosis or a delay in proper treatment
Z-1378-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K770287. One submission often covers many models, so check the product and lot details in each record.

Z-1377-2021 · Mar 17, 2021 · Terminated
BD BBL Martin-Lewis Agar, 100 Ea - Product Usage: used for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. Catalog Number: 22155

Device details

UDI-DI	`10382902215575`
Brand	BD BBL™ Martin-Lewis Agar
Model	221557
Company	Becton, Dickinson And Company
Product code	JTY · CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA
Class	Class 2
FDA submission	K770287
Implant	No
Rx / OTC	Prescription
Single use	Yes
Sterile	No
MRI safety	Labeling does not contain MRI Safety Information
Status	Not in Commercial Distribution
Record updated	Oct 25, 2023

Device type (GMDN): Differential/selective agar culture medium IVD

An agar culture medium intended to be used to promote the selective growth of a microbial species with specific characteristics (e.g., antibiotic resistance, ability to utilize, synthesize specific metabolites) and/or distinguish between microbial species growing on the same medium by appearance (e.g., colour, shape, growth pattern). It typically contains substances to inhibit the growth of commensal or contaminating microorganisms (e.g., antimicrobials, dyes, salts) and/or dyes or chemical indicators for differentiation.

Other CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA devices

BD BBL™ Martin-Lewis Agar 221558
Becton, Dickinson And Company · CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA
1 recall1 report
NA R01460
Remel, Inc. · Culture Media, For Isolation Of Pathogenic Neisseria
1 recall0 reports
NA R04030
Remel, Inc. · Culture Media, For Isolation Of Pathogenic Neisseria
1 recall0 reports
BD BBL™ Modified Thayer-Martin (MTM II) Agar 221568
Becton, Dickinson And Company · CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA
1 report

All CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA devices →

Sources and updates

Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.

How reports and recalls are matched · Editorial policy · Report an error on this page